A Comparative Study of Oral Nifedipine and Intravenous Labetalol for Acute Hypertensive Management in Pregnancy: Assessing Feto-Maternal Outcomes in a Hospital-based Randomized Control Trial.
Taranpreet KaurKalpana KumariPriyanka RaiVandana GuptaSarika Pandeynull VineetaShweta SainiPublished in: International journal of MCH and AIDS (2024)
Intravenous labetalol is faster in restoring blood pressure in pregnant women with preeclampsia than oral nifedipine and may be used as a first-line drug in the acute control of blood pressure in a hypertensive emergency during pregnancy. More studies are needed in order to evaluate the findings from this pilot study in a large sample of patients.
Keyphrases
- blood pressure
- liver failure
- hypertensive patients
- end stage renal disease
- respiratory failure
- drug induced
- pregnancy outcomes
- heart rate
- newly diagnosed
- high dose
- ejection fraction
- emergency department
- chronic kidney disease
- early onset
- healthcare
- prognostic factors
- pregnant women
- open label
- peritoneal dialysis
- clinical trial
- blood glucose
- placebo controlled
- preterm birth
- metabolic syndrome
- patient reported outcomes
- hepatitis b virus
- intensive care unit
- extracorporeal membrane oxygenation
- skeletal muscle
- study protocol
- glycemic control
- electronic health record